Physician profile
Chenyin He
NPI 1184833857
$1,999.11
in general payments reported to CMS, 2019-2025
14 companies · $992 in 2025
The $992 reported for 2025 was more than what 78% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.29 · 2021: $66.63 · 2022: $33.65 · 2023: $392 · 2024: $484 · 2025: $992.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,839 · Education: $29.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,839.08 |
| Education | $29.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fresenius USA Marketing, INC. | $653.70 | 2021-2025 | Velphoro, Velphoro, Korsuva |
| Astrazeneca Pharmaceuticals LP | $190.37 | 2019-2025 | Farxiga, Lokelma |
| Travere Therapeutics, INC. | $181.84 | 2023-2025 | |
| Ardelyx, INC. | $179.07 | 2023-2024 | Xphozah 30 Mg, Ibsrela |
| Nxstage Medical, INC. | $166.37 | 2023-2025 | Nxstage System One, Liberty Select Cycler |
| Apellis Pharmaceuticals, INC. | $110.68 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $100.80 | 2021-2025 | |
| Mallinckrodt Hospital Products INC. | $93.66 | 2025 | Acthar |
| Novartis Pharmaceuticals Corporation | $81.65 | 2025 | |
| Aurinia Pharma U.S., INC. | $60.35 | 2021-2024 | Lupkynis |
| Otsuka America Pharmaceutical, INC. | $59.67 | 2019-2023 | Jynarque |
| Amgen INC. | $55.24 | 2025 | Krystexxa |
| Horizon Therapeutics Plc | $38.95 | 2023 | Krystexxa |
| Glaxosmithkline, LLC. | $26.76 | 2023 | Jesduvroq, Benlysta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chenyin He listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.